List of Tables
    Table 1. Sustained Release Ocular Drug Delivery Systems CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Sustained Release Ocular Drug Delivery Systems Market Trends
    Table 3. Sustained Release Ocular Drug Delivery Systems Market Drivers
    Table 4. Sustained Release Ocular Drug Delivery Systems Market Challenges
    Table 5. Sustained Release Ocular Drug Delivery Systems Market Restraints
    Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Sustained Release Ocular Drug Delivery Systems Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Sustained Release Ocular Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Sustained Release Ocular Drug Delivery Systems Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Sustained Release Ocular Drug Delivery Systems Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer, (K Pcs), 2017-2022
    Table 14. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturer, 2017-2022
    Table 15. Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2017-2022) & (USD/Pcs)
    Table 16. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2021)
    Table 18. Top Players of Sustained Release Ocular Drug Delivery Systems in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
    Table 20. Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Sustained Release Ocular Drug Delivery Systems Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Sustained Release Ocular Drug Delivery Systems Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Sustained Release Ocular Drug Delivery Systems Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Sustained Release Ocular Drug Delivery Systems Sales by Players, (K Pcs), 2020, 2021 & 2022
    Table 26. United States Sustained Release Ocular Drug Delivery Systems Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2022) & (K Pcs)
    Table 29. Global Sustained Release Ocular Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
    Table 30. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Sustained Release Ocular Drug Delivery Systems Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 33. North America Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region (2017-2028) & (K Pcs)
    Table 35. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 37. Europe Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 39. Latin Americaa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume by Country (2017-2028) & (K Pcs)
    Table 41. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. pSivida Corporation Information
    Table 43. pSivida Description and Business Overview
    Table 44. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 45. pSivida Sustained Release Ocular Drug Delivery Systems Product
    Table 46. pSivida Recent Development
    Table 47. Allergan Corporation Information
    Table 48. Allergan Description and Business Overview
    Table 49. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 50. Allergan Product
    Table 51. Allergan Recent Development
    Table 52. Icon Bioscience Corporation Information
    Table 53. Icon Bioscience Description and Business Overview
    Table 54. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 55. Icon Bioscience Product
    Table 56. Icon Bioscience Recent Development
    Table 57. Ocular Therapeutix Corporation Information
    Table 58. Ocular Therapeutix Description and Business Overview
    Table 59. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 60. Ocular Therapeutix Product
    Table 61. Ocular Therapeutix Recent Development
    Table 62. Neurotech Pharmaceuticals Corporation Information
    Table 63. Neurotech Pharmaceuticals Description and Business Overview
    Table 64. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 65. Neurotech Pharmaceuticals Product
    Table 66. Neurotech Pharmaceuticals Recent Development
    Table 67. Santen Pharmaceutical Corporation Information
    Table 68. Santen Pharmaceutical Description and Business Overview
    Table 69. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 70. Santen Pharmaceutical Product
    Table 71. Santen Pharmaceutical Recent Development
    Table 72. Aciont Inc. Corporation Information
    Table 73. Aciont Inc. Description and Business Overview
    Table 74. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 75. Aciont Inc. Product
    Table 76. Aciont Inc. Recent Development
    Table 77. Envisia Therapeutics Corporation Information
    Table 78. Envisia Therapeutics Description and Business Overview
    Table 79. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 80. Envisia Therapeutics Product
    Table 81. Envisia Therapeutics Recent Development
    Table 82. GrayBug Corporation Information
    Table 83. GrayBug Description and Business Overview
    Table 84. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 85. GrayBug Product
    Table 86. GrayBug Recent Development
    Table 87. Innocore Pharmaceuticals Corporation Information
    Table 88. Innocore Pharmaceuticals Description and Business Overview
    Table 89. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 90. Innocore Pharmaceuticals Product
    Table 91. Innocore Pharmaceuticals Recent Development
    Table 92. OHR Pharmaceuticals Corporation Information
    Table 93. OHR Pharmaceuticals Description and Business Overview
    Table 94. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 95. OHR Pharmaceuticals Product
    Table 96. OHR Pharmaceuticals Recent Development
    Table 97. PolyActiva Corporation Information
    Table 98. PolyActiva Description and Business Overview
    Table 99. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 100. PolyActiva Product
    Table 101. PolyActiva Recent Development
    Table 102. TheraKine Corporation Information
    Table 103. TheraKine Description and Business Overview
    Table 104. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 105. TheraKine Product
    Table 106. TheraKine Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Sustained Release Ocular Drug Delivery Systems Customers List
    Table 110. Sustained Release Ocular Drug Delivery Systems Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Sustained Release Ocular Drug Delivery Systems Product Picture
    Figure 2. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Sustained Release Ocular Drug Delivery Systems Market Size 2017-2028 (US$ Million)
    Figure 4. Global Sustained Release Ocular Drug Delivery Systems Sales 2017-2028 (K Pcs)
    Figure 5. United States Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Sustained Release Ocular Drug Delivery Systems Market Size 2017-2028 (US$ Million)
    Figure 7. United States Sustained Release Ocular Drug Delivery Systems Sales 2017-2028 (K Pcs)
    Figure 8. United States Sustained Release Ocular Drug Delivery Systems Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Sustained Release Ocular Drug Delivery Systems Market Share in Global, in Volume (K Pcs) 2017-2028
    Figure 10. Sustained Release Ocular Drug Delivery Systems Report Years Considered
    Figure 11. Product Picture of Liposome
    Figure 12. Product Picture of Microcapsules/Nanocapsules
    Figure 13. Product Picture of Microspheres/Nanosptheres
    Figure 14. Product Picture of Implants
    Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2022 & 2028
    Figure 16. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028) & (K Pcs)
    Figure 19. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028) & (USD/Pcs)
    Figure 21. United States Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2022 & 2028
    Figure 22. United States Sustained Release Ocular Drug Delivery Systems Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Sustained Release Ocular Drug Delivery Systems Sales by Type (2017-2028) & (K Pcs)
    Figure 25. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Sustained Release Ocular Drug Delivery Systems Price by Type (2017-2028) & (USD/Pcs)
    Figure 27. Product Picture of Cataract
    Figure 28. Product Picture of Glaucoma
    Figure 29. Product Picture of Corneal Transplantation
    Figure 30. Product Picture of Others
    Figure 31. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2022 & 2028
    Figure 32. Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028) & (K Pcs)
    Figure 35. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028) & (USD/Pcs)
    Figure 37. United States Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2022 & 2028
    Figure 38. United States Sustained Release Ocular Drug Delivery Systems Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Sustained Release Ocular Drug Delivery Systems Sales by Application (2017-2028) & (K Pcs)
    Figure 41. United States Sustained Release Ocular Drug Delivery Systems Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Sustained Release Ocular Drug Delivery Systems Price by Application (2017-2028) & (USD/Pcs)
    Figure 43. North America Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 44. North America Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 48. Europe Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 55. Asia-Pacific Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 67. Latin America Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales in Volume Growth Rate 2017-2028 (K Pcs)
    Figure 72. Middle East & Africa Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Sustained Release Ocular Drug Delivery Systems Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Sustained Release Ocular Drug Delivery Systems Value Chain
    Figure 77. Sustained Release Ocular Drug Delivery Systems Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed